Revance Therapeutics, Inc.: SCHEDULE 13G/A filed May 15, 2025

Form type

SCHEDULE 13G/A

Filing date

May 15, 2025

Accession number

0000935836-25-000350

Filer

Revance Therapeutics, Inc. (CIK 1479290)